Related Experiment Video
Updated: Apr 15, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
The Chhattisgarh state screening programme for the sickle cell gene: a cost-effective approach to a public health
P K Patra1, P K Khodiar1, I R Hambleton2
1Department of Biochemistry, Pt. J.N.M. Medical College, Raipur, Chhattisgarh State, India.
Insights
Chhattisgarh
Area of Science:
- Hematology
- Public Health
- Genetics
Background:
- The Chhattisgarh State sickle haemoglobin screening program targets children aged 3-15 years.
- Over 1 million children have been screened across 7 districts in the last 6 years.
- The program aims to detect sickle cell disease and trait for management and genetic counseling.
Purpose of the Study:
- To implement and evaluate a large-scale sickle haemoglobin screening program in Chhattisgarh, India.
- To determine the frequency of sickle cell gene mutations in various social groups.
- To assess the effectiveness of screening for clinical management and genetic counseling.
Main Methods:
- Field screening using solubility tests on fingerprick samples.
- Confirmatory hemoglobin electrophoresis for positive cases.
- Analysis of sickle cell trait and SS phenotype frequencies across districts and social groups.
Main Results:
- Sickle cell trait frequency was 9.64%, and SS phenotype frequency was 0.29%.
- Most districts showed an excess of the SS phenotype, suggesting symptomatic selection.
- Other Backward Classes (OBCs) exhibited the highest frequencies of sickle cell gene mutations.
Conclusions:
- The screening program effectively detects sickle haemoglobin (HbS) for diagnosis.
- Genetic counseling is limited by the inability to detect co-inherited genes like HbD Punjab and beta-thalassemia trait.
- The program serves as a potential model for addressing sickle cell gene prevalence in large populations.
Abstract:
In India, the Chhattisgarh State screening programme for sickle haemoglobin focuses on children aged 3-15 years and has screened over 1,050,440 subjects over the last 6 years. Commencing in the District around the capital Raipur, this programme has now completed screening in 7 of the 27 Districts of Chhattisgarh State. Screening is initially performed by solubility tests on fingerprick samples in the field and those with positive tests have venipunctures for haemoglobin electrophoresis. The frequency of the sickle cell trait was 9.64 % and of the SS phenotype 0.29 % with only two Districts in Hardy-Weinberg equilibrium, most Districts showing an excess of the SS 'phenotype' most readily explained by symptomatic selection. The estimated costs were US$0.28 (solubility tests alone) and US$0.60 (haemoglobin electrophoresis). Of the social groupings commonly used in India, the OBC's (other backward classes) had the highest frequencies of the sickle cell gene mutations, followed by the Scheduled Tribes and the Scheduled Castes. The objectives of the programme were the detection of sickle cell disease for prospective clinical management and of the sickle cell trait for purposes of genetic counselling. The former objective is being met for diagnosis although the success of referral to clinic services requires audit. The objective of genetic counselling is compromised by the failure of the screening test to detect other genes of potential clinical significance such as HbD Punjab and the beta thalassaemia trait. Despite these exceptions, the detection of HbS appears relatively robust and could be another condition factored into the traditions of partner selection amongst the underprivileged communities of this state. Overall, the Chhattisgarh programme seeks to address the daunting challenges of large populations carrying the sickle cell gene and maybe a useful model for elsewhere.

